Nick Hunt

Nick is a co-founder and CEO of Endo Axiom. Endo Axiom is a biotechnology company focused on the prevention of autoimmune diseases and improving the quality of life for diabetics. The company develops platforms for the oral delivery of drugs and biologics, and brings these innovations through clinical validation. Endo Axiom's mission includes creating solutions for pharmaceutical challenges such as delivering oral insulin without hypoglycaemia and immune modulation for preventing type 1 diabetes without immune suppression. Nick is also a Senior Lecturer at the University of Sydney and the ANZAC Research Institute at Concord Hospital. His group develops nanotechnology platforms for the oral biologic delivery and inverse vaccinations for prevention of autoimmune diseases.

‍

Anthony Liveris

Anthony is the Chief Executive Officer and former Chief Operating Officer of Proto Axiom, a multi-stage life sciences investment firm with a strong focus on incubation.

Previously, Anthony co-founded Applecart, a platform generating over $30 million in annual revenue, which helps advertisers connect with high-value business decision-makers. He has also held roles working with Malcolm Turnbull, the Tony Blair Institute, and on the presidential campaigns of Mitt Romney and John Kasich.

Anthony serves as Chairman of the St. Vincent’s Hospital Discovery and Innovation Fund. He holds a Master of Public Policy (MPP) from the Blavatnik School of Government at the University of Oxford (2020) and a Bachelor of Arts (BA) from the University of Pennsylvania (2014).

‍